Do you have type 2 diabetes that is not adequately controlled with an anti-diabetes medication known as a GLP-1 for example Victoza®, Byetta ®, Bydureon®, Tanzeum®, Eperzan®, or Trulicity®?
You may qualify to participate in the clinical research study of an investigational anti-diabetes medication combined with insulin glargine to evaluate its effect on blood sugar levels, as compared to other anti-diabetes medication mentioned above.
Qualified participants will receive for free:
- Study-related medical examinations
- Study-related investigational medication
- Diabetes testing supplies
- Compensation for time and travel (where permitted)
- Diet and lifestyle counseling
- Are at least 18 years of age
- Have been diagnosed with type 2 diabetes for at least 1 year
- Have been treating your diabetes with other anti-diabetes medication called GLP-1 for example Victoza®, Byetta ®, Bydureon®, Tanzeum®, Eperzan®, or Trulicity® for at least 4-6 months and your diabetes is not adequately controlled with this treatment
Then you may be eligible to participate in this clinical research study.